We help companies develop vaccines using our patented lipid-based vaccine adjuvant system. If you have a protein based antigen, or nucleic acid, we will provide the liposome or lipid nanoparticle (LNP) for your vaccine R&D.
Our platform enables development of more effective and more stable vaccines across a wide temperature range (-40C to 40C). Please contact us today to find out more.
